Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2291020218
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. W.
Right arrow Articles by Chang, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. W.
Right arrow Articles by Chang, K. H.
(Radiology 2003;229:132-139.)
© RSNA, 2003


Experimental Studies

Contrast-enhanced MR Imaging of Postoperative Scars and VX2 Carcinoma in Rabbits: Comparison of Macromolecular Contrast Agent and Gadopentetate Dimeglumine1

Joon Woo Lee, MD, Woo Kyung Moon, MD, Hanns-Joachim Weinmann, PhD, Soo Jeoung Kim, PhD, Jong Hyo Kim, PhD, Seong Ho Park, MD, Tae Jung Kim, MD, Chang Jin Yoon, MD, Young Hoon Kim, MD, Eun Yoon Cho, MD, Sung Whan Ha, MD, Wee-Saing Kang, MD and Kee Hyun Chang, MD

1 From the Department of Radiology and Clinical Research Institute, Seoul National University Hospital and the Institute of Radiation Medicine, Seoul National University Medical Research Center, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea (J.W.L., W.K.M., S.J.K., J.H.K., S.H.P., T.J.K., C.J.Y., Y.H.K., K.H.C.); Department of Contrast Media Research, Schering, Berlin, Germany (H.J.W.); Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea (E.Y.C.); and Department of Therapeutic Radiology, Seoul National University Hospital, Korea (S.W.H., W.S.K.). From the 1999 RSNA scientific assembly. Received March 13, 2002; revision requested May 22; final revision received January 12, 2003; accepted February 24. Supported by a grant from Schering, Berlin, Germany. Address correspondence to W.K.M. (e-mail: moonwk@radcom.snu.ac.kr).

PURPOSE: To compare the magnetic resonance (MR) imaging enhancement patterns of a blood pool contrast agent, SH L 643A, with those of gadopentetate dimeglumine in postoperative scars and VX2 carcinomas in rabbits and to compare these enhancement patterns with microvessel density in pathologic specimens.

MATERIALS AND METHODS: Eighteen rabbits with experimentally induced postoperative scars (n = 12) or VX2 carcinoma (n = 6) in the thighs underwent sequential MR imaging first with gadopentetate dimeglumine and then, 24 hours later, with SH L 643A. The enhancement ratios (ie, the ratios of postcontrast to precontrast signal intensity) and the microvessel densities of postoperative scars and VX2 carcinomas were assessed. Differences were tested for by using the Mann-Whitney U and Wilcoxon signed rank tests.

RESULTS: In postoperative scars, enhancement ratios were consistently lower with injection of SH L 643A than with injection of gadopentetate dimeglumine for up to 30 minutes (P < .05). In postoperative scars, mean peak enhancement ratios were 1.29 ± 0.15 (SD) with injection of SH L 643A and 1.61 ± 0.31 with injection of gadopentetate dimeglumine (P < .01). In VX2 carcinomas, the enhancement ratios were not significantly different with injection of SH L 643A than with injection of gadopentetate dimeglumine at all time points. The mean difference between the enhancement ratios of the VX2 carcinomas and postoperative scars was 0.64 ± 0.10 (range, 0.50–0.77) with SH L 643A and 0.36 ± 0.16 (range, 0.17–0.66) with gadopentetate dimeglumine (P < .01). The mean microvessel density (in terms of vessels per field of view) was 10.7 ± 5.5 for postoperative scars and 30.0 ± 7.7 for VX2 carcinoma (P < .001).

CONCLUSION: The difference between the enhancement ratios of postoperative scars and VX2 carcinomas with SH L 643A was greater than that with gadopentetate dimeglumine. Enhancement ratios at SH L 643A–enhanced MR imaging corresponded well with microvessel density in postoperative scars and VX2 carcinomas.

© RSNA, 2003

Index terms: Animals • Contrast media, comparative studies • Experimental study • Gadolinium • Magnetic resonance (MR), contrast enhancement • Magnetic resonance (MR), contrast media • Neoplasms, MR




This article has been cited by other articles:


Home page
RadiologyHome page
N. M. Menezes, E. A. Olear, X. Li, S. A. Connolly, D. Zurakowski, M. Foley, F. Shapiro, and D. Jaramillo
Gadolinium-enhanced MR Images of the Growing Piglet Skeleton: Ionic versus Nonionic Contrast Agent.
Radiology, May 1, 2006; 239(2): 406 - 414.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Ni, F. Chen, G. Marchal, T. J. Kim, W. K. Moon, and S. N. Goldberg
Differentiation of Residual Tumor from Benign Periablational Tissues after Radiofrequency Ablation: The Role of MR Imaging Contrast Agents * Drs Kim and Moon respond: * Dr Goldberg responds:
Radiology, November 1, 2005; 237(2): 745 - 749.
[Full Text] [PDF]


Home page
RadiologyHome page
T. J. Kim, W. K. Moon, J. H. Cha, J. M. Goo, K. H. Lee, K. H. Kim, J. W. Lee, J. G. Han, H.-J. Weinmann, and K. H. Chang
VX2 Carcinoma in Rabbits after Radiofrequency Ablation: Comparison of MR Contrast Agents for Help in Differentiating Benign Periablational Enhancement from Residual Tumor
Radiology, February 1, 2005; 234(2): 423 - 430.
[Abstract] [Full Text] [PDF]